Abstract:Three tridentate Schiff base ligands were synthesized from the reactions between 2-picolylamine and salicylaldehyde derivatives (3-ethoxy (OEt), 4-diethylamino (NEt2) and 4-hydroxy (OH)). Complexes with the general formula Pt(N<^>N<^>O)Cl were obtained from reactions between the ligands and K2PtCl4. The ligands and their complexes were characterized by NMR spectroscopy, mass spectrometry and elemental analysis. Further confirmation of the structure of Pt-OEt was achieved by single-crystal X-ray diffraction. The DMSO/chlorido exchange process at Pt-OEt was investigated by monitoring the change in conductivity, revealing very slow dissociation in DMSO. Moreover, solvent/chlorido exchange for Pt-OEt and Pt-NEt2 were investigated by NMR spectroscopy in DMSO and DMSO/D2O; Pt-NEt2 forms an adduct with DMSO while Pt-OEt forms adducts with DMSO and water. The DNA-binding behaviour of the platinum(II) complexes was investigated by two techniques. Pt-NEt2 has the best apparent binding constant. The intercalation mode of interaction with ct-DNA was suggested by molecular docking studies and the increase in the relative viscosity of ct-DNA with increasing concentrations of the platinum(II) complexes. However, the gradual decrease in the relative viscosity over time at constant concentration of platinum(II) complexes indicated a shift from intercalation to a covalent binding mode. Anticancer activities of the ligands and their platinum(II) complexes were examined against two cell lines. The platinum(II) complexes exhibit superior cytotoxicity to that of their ligands. Among the platinum(II) complexes, Pt-OEt possesses the best IC50 against both cell lines, its cytotoxicity being comparable to that observed for cisplatin. Cell cycle arrest in the HepG2 cell line upon treatment with Pt-OEt and Pt-NEt2 was investigated and compared to that of cisplatin; the change in the cell accumulation patterns supports the presumption of an apoptotic cell death pathway. The optimized structures of the B-DNA trimer adducts with the platinum complexes showed hydrogen-bonding interactions between the ligands and nucleobases, affecting the inter-strand hydrogen bonding within the DNA, and highlighting the strong ability of the complexes to induce conformational changes in the DNA, leading to the activation of apoptotic cell death. In summary, the current study demonstrates promising new anticancer platinum(II) complexes with highly flexible tridentate ligands; the functional groups on the ligands are important in tuning their DNA binding/anticancer properties.

Platinum(II) complexes bearing the simplest olefin ligand: A new class potential for the development of anticancer drugs

Synthesis, characterization, and cytotoxicity of new types of binuclear platinum(II) complexes

Synthesis, characterization and cytotoxicity of iodo-bridged binuclear platinum(II) complexes.

Synthesis and Biological Activity of Binuclear Platinum Complexes Containing Two Monofunctional Cis-[Pt(Nh3)(2)Cl](+) Units Bridged by 4,4 '-Dipyridyl Selenides or Sulfides

Novel Cisplatin-Type Platinum Complexes and Their Cytotoxic Activity

Antitumor Platinum(II) Complexes with 1,10-phenanthroline and Hydrophilic Alkoxyacetates as Ligands.

Palladium(II) Complexes with N,N′-Dialkyl-1,10-phenanthroline-2,9-dimathanamine: Synthesis, Characterization and Cytotoxic Activity

Tuning the Anticancer Properties of Pt(ii) Complexes Via Structurally Flexible N-(2-picolyl)salicylimine Ligands.

Monofunctional Platinum Complexes Showing Potent Cytotoxicity Against Human Liver Carcinoma Cell Line Bel-7402

Synthesis and Anticancer Activity of [2-Hydroxy-1,3-diaminopropane-κ2n,n′] Platinum(ii) Complexes

Anticancer Potency of Platinum(Ii) Complexes Containing Both Chloride Anion and Chelated Carboxylate As Leaving Groups

Platinum(0)-η2-1,2-(E)ditosylethene Complexes Bearing Phosphine, Isocyanide and N-Heterocyclic Carbene Ligands: Synthesis and Cytotoxicity towards Ovarian and Breast Cancer Cells

Synthesis, Characterization and Antitumor Activity of New Type Binuclear Platinum(ii) Complexes.

Tuning Anticancer Properties and DNA-binding of Pt(ii) Complexes Via Alteration of Nitrogen Softness/basicity of Tridentate Ligands.

Synthesis, structures, and anticancer potentials of four platinum (II) complexes with benzopyran derivatives targeting mitochondria

Antiproliferative Activity of Platinum(II) and Copper(II) Complexes Containing Novel Biquinoxaline Ligands

Synthesis and Antitumor Activity of Dinuclear Platinum Complexes with (1(i)R, 1(ii)R, 2(i)R, 2(ii)R)-N-i,N-ii-(1, 3-Phenylenebis(methylene))dicyclohexane-1, 2-diamie as the Ligand

Effect of geometric isomerism on the anticancer property of new platinum complexes with glycine derivatives as asymmetric N, O donate ligands against human cancer

Palladium and platinum complexes based on pyridine bases induced anticancer effectiveness via apoptosis protein signaling in cancer cells

Novel antitumor dinuclear platinum (II) complexes with a new chiral tetradentate ligand as the carrier group

Synthesis, Characterization, and Cytotoxicity Evaluation of Novel Water‐Soluble Cationic Platinum(II) Organometallic Complexes with Phenanthroline and Imidazolic Ligands